TJ BIOTECH HOLDING ApS

APSDissolved

CVR 26415365Pile Alle 20, 2840 HolteVirksomhedsrådgivning og anden rådgivning om driftsledelse· NACE 702200Est. 2001 · 24 years old1 employees

Overview

TJ BIOTECH HOLDING ApS is a Danish APS based in Holte, operating in the Virksomhedsrådgivning og anden rådgivning om driftsledelse sector. Incorporated in 2001, the company has 1 employee and reported a gross profit of DKK 957.2k in its latest annual filing.

Gross profit 2019

1M DKK

−1% vs 2018

EBITDA margin (of gross profit)

−17.8 %

+29% vs 2018

Net profit 2019

0.3M DKK

-57% vs 2018

Key ratios

See full ratios →

97.5 %

Very strong

Among the 20% highest rated companies in the industry

20152019

5.6×

Strong

Among the 30% highest rated companies in the industry

20152019

1.9 %

Average

Around the average of companies in the same industry

20152019

EBITDA — year on year

DKK thousands

Key figures

Annual report 2019

Gross profit	1M DKK	-1%
EBITDA	-0.2M DKK	+29%
Net profit	0.3M DKK	-57%
Total assets	18.8M DKK	+2%
Equity	18.3M DKK	+2%
Employees	1	—

Financial development

In its most recent annual report (2019), TJ BIOTECH HOLDING ApS reported a gross profit of DKK 957.2k, a decrease of 1% on the year before. The figures on this page draw on 5 annual filings covering 2015 to 2019. The bottom line showed a net profit of DKK 347.5k, and the EBITDA margin stood at -17.8%.

At the end of 2019, equity financed 97.5% of the balance sheet, and current assets covered short-term debt 5.6 times.

Financials

Gross profit

DKK thousands

EBITDA

DKK thousands

Income statement

DKK thousands

Item	2019	2018	2017	2016	2015
Gross profit	957	963	944	886	-12
Staff expenses	-1,128	-1,202	-979	-300	-0
EBITDA	-171	-239	-36	586	-12
Depreciation & amort.	-0	-0	-0	-0	-0
EBIT	-171	-239	-36	586	-12
Net financials	518	1,041	4,299	12,409	-83
Profit before tax	347	802	4,263	12,995	-95
Tax	-0	-0	31	110	-0
Net profit	347	802	4,233	12,884	-95

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2019	2018	2017	2016	2015
Total assets	18,767	18,351	17,713	13,312	192
Equity	18,300	17,953	17,151	12,918	34
Long-term debt	0	0	0	0	0
Short-term debt	467	399	562	394	159
Total debt	467	399	562	394	159

Financial ratios

5-year trend

EBITDA margin (of gross profit)

-17.8 %

20152019

Equity ratio

97.5 %

Very strong

Among the 20% highest rated companies in the industry

20152019

Return on equity

1.9 %

Weak

Among the 40% lowest rated companies in the industry

20152019

Net profit margin (of gross profit)

36.3 %

20152019

Asset turnover (of gross profit)

0.05×

20152019

Debt / equity

0.03×

Very strong

Among the 10% highest rated companies in the industry

20152019

Sector performance

23 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Return on equity (ROE)Weak

Among the 40% lowest rated companies in the industry

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on assets (ROA)Average

Around the average of companies in the same industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Return on net assets (RONA)Weak

Among the 40% lowest rated companies in the industry

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Basic earning power (BEP)Weak

Among the 40% lowest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Capacity ratioWeak

Among the 30% lowest rated companies in the industry

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Gross marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Liquidity

Current ratioStrong

Among the 30% highest rated companies in the industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioStrong

Among the 30% highest rated companies in the industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioAverage

Around the average of companies in the same industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Current assets to equityVery strong

Among the 10% highest rated companies in the industry

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Fixed assets to long-term capitalVery weak

Among the 20% lowest rated companies in the industry

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Cash conversion ratioVery weak

Among the 10% lowest rated companies in the industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Debt & solvency

Solidity ratioVery strong

Among the 20% highest rated companies in the industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioVery strong

Among the 10% highest rated companies in the industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Debt to equityVery strong

Among the 10% highest rated companies in the industry

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityVery strong

Among the 20% highest rated companies in the industry

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Income to debtStrong

Among the 30% highest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtVery weak

Among the 20% lowest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageVery weak

Among the 20% lowest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtWeak

Among the 40% lowest rated companies in the industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginAverage

Around the average of companies in the same industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Efficiency & development

Equity to contributed capitalVery strong

Among the 10% highest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in equityAverage

Around the average of companies in the same industry

The size of this year's increase or decrease in the company's equity.

One-year change in debtWeak

Among the 40% lowest rated companies in the industry

The size of this year's increase or decrease in the company's debt.

Asset turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to total assets — the ability to generate revenue from the asset base.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

Annual reports & filings

Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View PDF
Annual report 2017
Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
View PDF
Annual report 2016
Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
View PDF
Annual report 2015
Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
View PDF

People & ownership

Management

Actively employed in the business

No data on file.

Board of directors

Non-executive oversight

No data on file.

Shareholders

Active legal owners

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

No registered parent or subsidiaries

Frequently asked questions

What is the CVR number of TJ BIOTECH HOLDING ApS?

TJ BIOTECH HOLDING ApS is registered with CVR / Virk under CVR 26415365.

What is the gross profit of TJ BIOTECH HOLDING ApS?

TJ BIOTECH HOLDING ApS reported a gross profit of DKK 957.2k in 2019.

How many employees does TJ BIOTECH HOLDING ApS have?

TJ BIOTECH HOLDING ApS employs 1 people as of the latest annual report.

Where is TJ BIOTECH HOLDING ApS headquartered?

TJ BIOTECH HOLDING ApS's registered address is Pile Alle 20.